Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab

被引:0
|
作者
Raslan, Walid [1 ]
Younis, Saad [1 ]
Fabozzi, Lorenzo [2 ]
Hassan, Islam [1 ]
Palmieri, Filomena [1 ]
机构
[1] Western Eye Hosp London, London, England
[2] Moorfields Eye Hosp NHS Fdn Trust London, London, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Two Year Real World Outcomes of Ranibizumab Therapy for Neovascular Age Related Macular Degeneration (nAMD)
    Bhalla, Minak
    Muniraju, Ramu
    OPHTHALMOLOGICA, 2014, 232 : 4 - 4
  • [42] Predicting visual outcomes in patients treated with aflibercept for neovascular age-related macular degeneration: Data from a real-world clinical setting
    Fulcher, Corinne
    Hazel, Charlotte A.
    Pacey, Ian
    Ali, Hasan
    Ghanchi, Faruque D.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (03) : 543 - 549
  • [43] REAL WORLD EFFICACY AND DURABILITY OF FARICIMAB IN SUB-OPTIMAL RESPONDER PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Hernaez, Jimena Soto
    Goodchild, Christine
    Bailey, Clare
    Ahmed, Eslam
    Salvatore, Serena
    EYE, 2024, 38 : 162 - 163
  • [44] ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD)
    Liakopoulos, Sandra
    Spital, Georg
    Brinkmann, Christian K.
    Schick, Tina
    Ziemssen, Focke
    Voegeler, Jessica
    Koch, Mirja
    Kirchhof, Bernd
    Holz, Frank G.
    Pauleikhoff, Daniel
    Schmitz-Valckenberg, Steffen
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2020, 104 (11) : 1573 - 1578
  • [45] The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study-2 Year Results
    Aziz, Aamir Abdul
    Khan, Hannah
    Barakat, Mark Rami
    Bhandari, Ramanath
    Chang, Emmanuel
    Corradetti, Giulia
    Danzig, Carl J.
    Graff, Jordan M.
    London, Nikolas J. S.
    Nielsen, Jared
    Sheth, Veeral
    Wolfe, Jeremy
    Wong, Robert William
    Sadda, SriniVas R.
    Singer, Michael Andrew
    Khanani, Arshad M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [46] The Short-Term Efficacy and Safety of Faricimab in Refractory Neovascular Age-Related Macular Degeneration: The Real-World Experience in Taiwan
    Chi, Sheng-Chu
    Weng, Chang-Chi
    Chen, Shih-Jen
    Lin, Tai-Chi
    Chou, Yu-Bai
    Hwang, De-Kuang
    OPHTHALMOLOGICA, 2024, 247 (5-6) : 312 - 321
  • [47] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study-6 month results
    Khanani, Arshad M.
    Aziz, Aamir A.
    Khan, Hannah
    Gupta, Ashwin
    Mojumder, Ohidul
    Saulebayeva, Aigerim
    Abbey, Ashkan M.
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark R.
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara J.
    London, Nikolas J. S.
    Mein, Luke
    Sheth, Veeral S.
    Wolfe, Jeremy D.
    Singer, Michael A.
    Danzig, Carl J.
    EYE, 2023, 37 (17) : 3574 - 3581
  • [48] Real-World Prevalence and Progress of Intraretinal and Subretinal Fluid in Eyes Switched to Faricimab for the treatment of Neovascular Age-Related Macular Degeneration
    Karamat, Ayesha Nuri
    Mauger, Stephanie
    O'Neill, Charles Patrick
    Urrea, Anna
    Corradetti, Giulia
    Chauhan, Devinder
    Samarasinghe, Gihan
    Sadda, SriniVas R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [49] Changes in Quality of Life Among Patients Treated with Aflibercept for neovascular Age-related Macular Degeneration (nAMD)
    Wijeyakumar, Wijeyanthy
    Hong, Thomas
    Broadhead, Geoffrey
    Li, Haitao
    Zhu, Meidong
    Chang, Andrew Alexander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [50] Real -world efficacy of switching to faricimab therapy in patients with longstanding neovascular age -related macular degeneration
    Long Phan
    Chin, Jennifer
    Hong, Thomas
    Chang, Andrew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)